Assignee
PANACEA PHARMACEUTICALS INC
US·7 granted patents·8 pending applications·66 citations·filing 2001–2020
Top patents by PatentIndex Score
15 records- 0191US6780971B2Compositions for inhibiting the aggregation pathway of α-synucleinPANACEA PHARMACEUTICALS INC·Filed 2001·Granted Aug 24, 2004·51 cites·4 claims
- 0279US9744223B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2013·Granted Aug 29, 2017·4 cites·9 claims
- 0373US7521479B2Methods of treating prion disease in mammalsPANACEA PHARMACEUTICALS INC·Filed 2001·Granted Apr 21, 2009·3 cites·14 claims
- 0471US7605133B2Isolated peptides to treat alpha-synuclein diseasesPANACEA PHARMACEUTICALS INC·Filed 2004·Granted Oct 20, 2009·2 cites·12 claims
- 0567US7456179B2Methods of treating ischemic related conditionsPANACEA PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·6 cites·1 claims
- 0663US10702591B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylasePANACEA PHARMACEUTICALS INC·Filed 2017·Granted Jul 7, 2020·0 cites·6 claims
- 0758US2020246443A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0856US2021148915A9Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsPANACEA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0953US2008124718A1Methods of diagnosing, predicting therapeutic efficacy and screening for new therapeutic agents for leukemiaPANACEA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1052US2017072034A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1151US2004146945A1Olfactory neuron cultures and method of making and using the samePANACEA PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1251US2004146946A1Olfactory neuron cultures and method of making and using the samePANACEA PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1344US10166303B2Radio-imaging and radio-therapy of cancer using antibodies to HAAHPANACEA PHARMACEUTICALS INC·Filed 2016·Granted Jan 1, 2019·0 cites·12 claims
- 1444US2020390902A1Antibody-Drug Conjugates Targeted at Human Aspartyl-(Asparaginyl)-B-Hydroxylase (HAAH)PANACEA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1542US2019049455A1HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when CombinedPANACEA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →